After an executive order, the FDA announced it would prioritize the study of some psychedelic drugs for therapeutic use. Which did they choose and why?

Trendy peptide injections boasted by Health Secretary Robert F. Kennedy Jr. and wellness influencers like Joe Rogan may soon get a boost from the FDA.

On Feb. 1, 2026, the FDA officially launched its Manufacturing PreCheck Pilot Program, which is intended to de-risk and accelerate the establishment of U.S. pharmaceutical manufacturing facilities by increasing regulatory predictability, facilitating ...

Corrections and clarifications: Due to an editing error, a previous version of this story mischaracterized the scope of the new FDA approval for leucovorin. In a White House briefing on Sept. 22, Trump, Kennedy, and other officials made several ...

WASHINGTON (AP) — Americans who smoke may soon be hearing a lot more about Zyn, the flavored nicotine pouches that have generated billions in sales while going viral on social media. Trump signs order on psychedelics to ease FDA restrictions ‘It’s a ...

The US Food and Drug Administration (FDA) is, like many device regulatory bodies around the world, preparing to implement a huge overhaul of its medical device systems. Known as the Unique Device Identification (UDI) rule, the US regulator wants to build a ...

U.S. Senate Committee on Health, Education, Labor, and Pensions Chair Bill Cassidy (R-La.) in February 2026 released a report, "Patients and Families First: Building the FDA of the Future," that outlines priorities for modernizing the U.S. Food and Drug ...